CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $513,200
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$513,200. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Todisco Joseph Chief Executive Officer | Purchase | +80,000 | $4.89 | $391K | 854,749 |
| 2026-02-04 | Todisco Joseph Chief Executive Officer | Grant or award | +77,156 | 774,749 | ||
| 2026-01-23 | Todisco Joseph Chief Executive Officer | Grant or award | +225,900 | 724,899 | ||
| 2026-01-23 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −27,306 | $7.27 | $199K | 697,593 |
| 2026-01-17 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −22,665 | $6.78 | $154K | 498,999 |
| 2026-01-16 | Todisco Joseph Chief Executive Officer | Exercise or conversion | +29,585 | $3.38 | $100K | 521,664 |
| 2026-01-16 | Todisco Joseph Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −29,585 | 411,245 | ||
| 2026-01-12 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −17,417 | $7.15 | $125K | 492,079 |
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Exercise or conversion 10b5-1 | +30,000 | $4.43 | $133K | 539,496 |
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Sale 10b5-1 | −30,000 | $12.00 | $360K | 509,496 |
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −30,000 | 370,000 | ||
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Exercise or conversion | +50,000 | $3.47 | $174K | 559,496 |
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Sale | −50,000 | $13.00 | $650K | 509,496 |
| 2025-09-12 | Todisco Joseph Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −50,000 | 216,667 | ||
| 2025-05-10 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −21,225 | $11.66 | $247K | 509,496 |
| 2025-04-01 | Todisco Joseph Chief Executive Officer | Exercise or conversion | +59,170 | $3.38 | $200K | 530,721 |
| 2025-04-01 | Todisco Joseph Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −59,170 | 440,830 | ||
| 2025-01-17 | Todisco Joseph Chief Executive Officer | Grant or award | +187,500 | 495,528 | ||
| 2025-01-17 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −23,977 | $12.17 | $292K | 471,551 |
| 2025-01-10 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −17,829 | $11.19 | $200K | 308,028 |
Page 1 of 2 · 35 trades